title: Advantage of salivary cortisol measurements in the diagnosis of glucocorticoid related disorders.
abstract: OBJECTIVE
  Salivary cortisol in the assessment of glucocorticoid related disorders. DESIGN-METHODS: Serum and salivary cortisol were measured in 189 patients (22 Cushing's syndrome, 67 pseudo-Cushing, 11 Addison's disease, 89 controls) at 8:00 and 24:00 h.
  
  
  RESULTS
  Serum and salivary cortisol correlated in the whole study population (r=0.62, p=0.000). Morning serum and saliva cortisol in Addison's disease were lower than in controls (6.74+/-1.69 vs 22.58+/-1.78 microg/dL, and 0.15+/-0.25 vs 0.67+/-0.12 microg/dL) (p<0.001). Morning serum cortisol was similar in controls and patients with Cushing's syndrome or pseudo-Cushing (22.58+/-1.78 vs 13.96+/-6.02 vs 16.13+/-1.69 microg/dL). Morning serum and salivary cortisol at 8:00 had the same sensitivity to distinguish patients with Addison's disease from healthy controls. 24:00 am serum cortisol in controls (2.61+/-0.20 microg/dL) was lower than in the pseudo-Cushing group (6.53+/-0.77 microg/dL, p<0.001) and in Cushing's syndrome (10.90+/-2.36 microg/dL, p=0.003). 24:00 am salivary cortisol in controls (0.0025+/-0.001 microg/dL) was lower than in patients with Cushing's syndrome (0.58+/-0.11 microg/dL, p<0.001) and those higher than in patient with pseudo-Cushing (0.10+/-0.06 microg/dL, p=0.001). Both salivary cortisol and serum cortisol presented high specificity (82% and 100%) to detect Cushing's syndrome but salivary cortisol higher sensitivity (saliva 88% and serum 50%).
  
  
  CONCLUSIONS
  Morning salivary cortisol is as good as serum as screening test for patients with Addison's disease and nighttime salivary cortisol is more adequate than serum in the screening of Cushing's syndrome.
authors.affiliation: Clinical Chemistry Department, University Clinic of Navarra, University of Navarra, Pamplona, Spain.
authors.forename: P
authors.initials: P
authors.lastname: Restituto
authors.forename: J C
authors.initials: JC
authors.lastname: Galofré
authors.forename: M J
authors.initials: MJ
authors.lastname: Gil
authors.forename: C
authors.initials: C
authors.lastname: Mugueta
authors.forename: S
authors.initials: S
authors.lastname: Santos
authors.forename: J I
authors.initials: JI
authors.lastname: Monreal
authors.forename: N
authors.initials: N
authors.lastname: Varo
mesh_terms: D000224:Addison Disease / Q000097:blood / Q000175:diagnosis / Q000378:metabolism; D000307:Adrenal Gland Diseases / Q000097:blood / Q000175:diagnosis* / Q000378:metabolism; D000328:Adult; D000368:Aged; D003480:Cushing Syndrome / Q000097:blood / Q000175:diagnosis / Q000378:metabolism; D005260:Female; D005938:Glucocorticoids / Q000032:analysis* / Q000097:blood / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000032:analysis* / Q000097:blood / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D012463:Saliva / Q000737:chemistry* / Q000378:metabolism
chemical_list: D005938:Glucocorticoids; D006854:Hydrocortisone